Endpoints at #JPM25 - January 13-14, 2025 - San Francisco
In the biopharma world, the new year doesn’t start on January 1 — it starts when the industry descends on San Francisco for JPM. Dealmakers, investors, and corporate leaders will gather …
Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
Eli Lilly, Pfizer stress independence of telehealth partners in ...
Dec 3, 2024 · In response to lawmakers' concerns, Pfizer and Eli Lilly said last week that they do not influence telehealth partners and their clinicians to prescribe their brand-name drugs.
Developing your new medicine in Japan faster
Nov 14, 2024 · Getting new medicines developed in Japan is now easier, thanks to regulatory streamlining and changes in the pricing system. Senior Japanese government officials and …
Ahead of adcomm, FDA discusses Seikagaku’s mixed trial results …
Jan 8, 2025 · Japan-based Seikagaku will face an FDA advisory committee on Friday, with the agency raising concerns ahead of the meeting regarding the efficacy of its condoliase injection …
Federal appeals court says Teva must delist Orange Book inhaler …
Dec 23, 2024 · The Federal Trade Commission is praising an appeals court decision calling for Teva to delist five inhaler patents from the FDA’s Orange Book.
The Endpoints 100 survey: What are biopharma execs saying …
Dec 11, 2024 · We’ve asked our advisory group in the E100 about how things are shaping up at the FDA and HHS under the new Trump administration and what impact prospective changes …
News – Page 1128 – Endpoints News
reset password. We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours. email
Agenda: Endpoints at #JPM25 - events.endpts.com
Jan 13, 2025 · How a new Washington affects biopharma: In conversation with Scott Gottlieb . Investor, policy expert and former FDA Commissioner Scott Gottlieb will share his insights on …
The Endpoints 100: The biotech industry braces for Trump 2.0
Dec 11, 2024 · A survey of 77 biotech executives reveals concerns about FDA changes following Donald Trump's reelection. Martin Makary's nomination as FDA chief has eased some worries, …